Vanda Pharmaceuticals (VM4.F) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.18
-0.1
-0.03
0.05

Details

Expected EPS
-0.14377800591
Actual EPS
-0.0825957
Surprise EPS
0.06
Surprise Percent
+42.55%

Description

Vanda Pharmaceuticals (VM4.F) has reported earnings of -0.0825957 per share for Q4 2024.

0 Comments

Share your thoughts